Structure Therapeutics (GPCR) Retained Earnings (2022 - 2026)
Quarterly Retained Earnings fell 67130.67% to -$546.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$546.3 million through Mar 2026, down 67130.67% year-over-year, with the annual reading at $1.1 million for FY2025, 15.32% up from the prior year.
Structure Therapeutics' Retained Earnings history spans 5 years, with the latest figure at -$546.3 million for Q1 2026.
- Retained Earnings came in at -$546.3 million for Q1 2026, down from $1.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $2.8 million in Q3 2024 to a low of -$546.3 million in Q1 2026.
- The 5-year median for Retained Earnings is -$288500.0 (2024), against an average of -$138.5 million.
- The largest YoY upside for Retained Earnings was 1005.56% in 2025 against a maximum downside of 89756.26% in 2025.
- Structure Therapeutics' Retained Earnings stood at -$117.0 million in 2022, then skyrocketed by 100.45% to $521000.0 in 2023, then skyrocketed by 75.43% to $914000.0 in 2024, then rose by 15.32% to $1.1 million in 2025, then plummeted by 51931.12% to -$546.3 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Retained Earnings are -$546.3 million (Q1 2026), $1.1 million (Q4 2025), and -$503.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -546.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -546.30 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | -503.30 Mn |
| Jun 30, 2025 | -437.60 Mn |
| Mar 31, 2025 | 815,000.00 |
| Dec 31, 2024 | 914,000.00 |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | -487,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Dec 31, 2023 | 521,000.00 |
| Sep 30, 2023 | -182.07 Mn |
| Jun 30, 2023 | -158.20 Mn |
| Mar 31, 2023 | 147,000.00 |
| Dec 31, 2022 | -116.95 Mn |